Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism

Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism. The freezing of gait episodes (FOG) normally appear during the off period and generally improve with dopaminergic stimulus, at the same time as improving other Parkinsonian symptoms. We report a group of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurología (Barcelona, Spain) Spain), 2010-01, Vol.25 (1), p.27-31
Hauptverfasser: Vaamonde Gamo, J, Cabello, J P, Gallardo Alcañiz, M J, Flores Barragan, J M, Carrasco García de León, S, Ibañez Alonso, R E
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 31
container_issue 1
container_start_page 27
container_title Neurología (Barcelona, Spain)
container_volume 25
creator Vaamonde Gamo, J
Cabello, J P
Gallardo Alcañiz, M J
Flores Barragan, J M
Carrasco García de León, S
Ibañez Alonso, R E
description Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism. The freezing of gait episodes (FOG) normally appear during the off period and generally improve with dopaminergic stimulus, at the same time as improving other Parkinsonian symptoms. We report a group of 10 patients with severe Parkinson's disease. All patients suffered motor fluctuations, dyskinesias and episodes of FOG during the on and off state. The patients received a subcutaneous apomorphine bolus, without other dopaminergic medication; an effective dose of apomorphine was considered as one that induced a reduction of at least a 60% in the UPDRS motor scale. The baseline motor UPDRS was 61.3 +/- 4.7, which dropped to 21 +/- 4.3 after the apomorphine injection. The mean dose of apomorphine was 5.5 mg (3-7 mg). The bolus of apomorphine improved the parameters of the gait related to bradykinesia and the tapping tests of the limbs, but the episodes of FOG did not vary significantly between the off and on state. We present a group of 10 patients with freezing of gait episodes that did not improve with treatment and persisted during the on period induced by dopaminergic stimulus with apomorphine.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_756294944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>756294944</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-7b39931abd99d199bb13bcfa7314da4dd1aa18fd869c0aa76975fc79df02e4ab3</originalsourceid><addsrcrecordid>eNo1kLFOwzAURT2AaCn8AvLGFMmOnTgeUUUBqRIMsBI9xy_FkNjBdorg66lEmc4dju5wTsiSlVwUsqnEgpyn9M5YWWlZn5FFyUTTyKpZktdNRPxxfkdDT3fgMp19xDQFn9weaQ7UhglG5zHuXEdTduM8QHbBU-fpdFjoc6JfLr_RhHuMSJ8gfjifgndpvCCnPQwJL49ckZfN7fP6vtg-3j2sb7bFxCXLhTJCa8HBWK0t19oYLkzXgxJcWpDWcgDe9LapdccAVK1V1XdK256VKMGIFbn--51i-Jwx5XZ0qcNhAI9hTq2q6lJLLeXBvDqasxnRtlN0I8Tv9j-J-AVoHl8q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756294944</pqid></control><display><type>article</type><title>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Vaamonde Gamo, J ; Cabello, J P ; Gallardo Alcañiz, M J ; Flores Barragan, J M ; Carrasco García de León, S ; Ibañez Alonso, R E</creator><creatorcontrib>Vaamonde Gamo, J ; Cabello, J P ; Gallardo Alcañiz, M J ; Flores Barragan, J M ; Carrasco García de León, S ; Ibañez Alonso, R E</creatorcontrib><description>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism. The freezing of gait episodes (FOG) normally appear during the off period and generally improve with dopaminergic stimulus, at the same time as improving other Parkinsonian symptoms. We report a group of 10 patients with severe Parkinson's disease. All patients suffered motor fluctuations, dyskinesias and episodes of FOG during the on and off state. The patients received a subcutaneous apomorphine bolus, without other dopaminergic medication; an effective dose of apomorphine was considered as one that induced a reduction of at least a 60% in the UPDRS motor scale. The baseline motor UPDRS was 61.3 +/- 4.7, which dropped to 21 +/- 4.3 after the apomorphine injection. The mean dose of apomorphine was 5.5 mg (3-7 mg). The bolus of apomorphine improved the parameters of the gait related to bradykinesia and the tapping tests of the limbs, but the episodes of FOG did not vary significantly between the off and on state. We present a group of 10 patients with freezing of gait episodes that did not improve with treatment and persisted during the on period induced by dopaminergic stimulus with apomorphine.</description><identifier>ISSN: 0213-4853</identifier><identifier>PMID: 20388458</identifier><language>spa</language><publisher>Spain</publisher><subject>Aged ; Antiparkinson Agents - therapeutic use ; Apomorphine - therapeutic use ; Dopamine - therapeutic use ; Dopamine Agents - therapeutic use ; Dyskinesias - drug therapy ; Dyskinesias - etiology ; Dyskinesias - physiopathology ; Gait ; Humans ; Middle Aged ; Parkinson Disease - complications ; Parkinson Disease - drug therapy ; Parkinson Disease - physiopathology ; Treatment Outcome</subject><ispartof>Neurología (Barcelona, Spain), 2010-01, Vol.25 (1), p.27-31</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20388458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaamonde Gamo, J</creatorcontrib><creatorcontrib>Cabello, J P</creatorcontrib><creatorcontrib>Gallardo Alcañiz, M J</creatorcontrib><creatorcontrib>Flores Barragan, J M</creatorcontrib><creatorcontrib>Carrasco García de León, S</creatorcontrib><creatorcontrib>Ibañez Alonso, R E</creatorcontrib><title>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism</title><title>Neurología (Barcelona, Spain)</title><addtitle>Neurologia</addtitle><description>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism. The freezing of gait episodes (FOG) normally appear during the off period and generally improve with dopaminergic stimulus, at the same time as improving other Parkinsonian symptoms. We report a group of 10 patients with severe Parkinson's disease. All patients suffered motor fluctuations, dyskinesias and episodes of FOG during the on and off state. The patients received a subcutaneous apomorphine bolus, without other dopaminergic medication; an effective dose of apomorphine was considered as one that induced a reduction of at least a 60% in the UPDRS motor scale. The baseline motor UPDRS was 61.3 +/- 4.7, which dropped to 21 +/- 4.3 after the apomorphine injection. The mean dose of apomorphine was 5.5 mg (3-7 mg). The bolus of apomorphine improved the parameters of the gait related to bradykinesia and the tapping tests of the limbs, but the episodes of FOG did not vary significantly between the off and on state. We present a group of 10 patients with freezing of gait episodes that did not improve with treatment and persisted during the on period induced by dopaminergic stimulus with apomorphine.</description><subject>Aged</subject><subject>Antiparkinson Agents - therapeutic use</subject><subject>Apomorphine - therapeutic use</subject><subject>Dopamine - therapeutic use</subject><subject>Dopamine Agents - therapeutic use</subject><subject>Dyskinesias - drug therapy</subject><subject>Dyskinesias - etiology</subject><subject>Dyskinesias - physiopathology</subject><subject>Gait</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - physiopathology</subject><subject>Treatment Outcome</subject><issn>0213-4853</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kLFOwzAURT2AaCn8AvLGFMmOnTgeUUUBqRIMsBI9xy_FkNjBdorg66lEmc4dju5wTsiSlVwUsqnEgpyn9M5YWWlZn5FFyUTTyKpZktdNRPxxfkdDT3fgMp19xDQFn9weaQ7UhglG5zHuXEdTduM8QHbBU-fpdFjoc6JfLr_RhHuMSJ8gfjifgndpvCCnPQwJL49ckZfN7fP6vtg-3j2sb7bFxCXLhTJCa8HBWK0t19oYLkzXgxJcWpDWcgDe9LapdccAVK1V1XdK256VKMGIFbn--51i-Jwx5XZ0qcNhAI9hTq2q6lJLLeXBvDqasxnRtlN0I8Tv9j-J-AVoHl8q</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>Vaamonde Gamo, J</creator><creator>Cabello, J P</creator><creator>Gallardo Alcañiz, M J</creator><creator>Flores Barragan, J M</creator><creator>Carrasco García de León, S</creator><creator>Ibañez Alonso, R E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201001</creationdate><title>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism</title><author>Vaamonde Gamo, J ; Cabello, J P ; Gallardo Alcañiz, M J ; Flores Barragan, J M ; Carrasco García de León, S ; Ibañez Alonso, R E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-7b39931abd99d199bb13bcfa7314da4dd1aa18fd869c0aa76975fc79df02e4ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Antiparkinson Agents - therapeutic use</topic><topic>Apomorphine - therapeutic use</topic><topic>Dopamine - therapeutic use</topic><topic>Dopamine Agents - therapeutic use</topic><topic>Dyskinesias - drug therapy</topic><topic>Dyskinesias - etiology</topic><topic>Dyskinesias - physiopathology</topic><topic>Gait</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - physiopathology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaamonde Gamo, J</creatorcontrib><creatorcontrib>Cabello, J P</creatorcontrib><creatorcontrib>Gallardo Alcañiz, M J</creatorcontrib><creatorcontrib>Flores Barragan, J M</creatorcontrib><creatorcontrib>Carrasco García de León, S</creatorcontrib><creatorcontrib>Ibañez Alonso, R E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Neurología (Barcelona, Spain)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaamonde Gamo, J</au><au>Cabello, J P</au><au>Gallardo Alcañiz, M J</au><au>Flores Barragan, J M</au><au>Carrasco García de León, S</au><au>Ibañez Alonso, R E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism</atitle><jtitle>Neurología (Barcelona, Spain)</jtitle><addtitle>Neurologia</addtitle><date>2010-01</date><risdate>2010</risdate><volume>25</volume><issue>1</issue><spage>27</spage><epage>31</epage><pages>27-31</pages><issn>0213-4853</issn><abstract>Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism. The freezing of gait episodes (FOG) normally appear during the off period and generally improve with dopaminergic stimulus, at the same time as improving other Parkinsonian symptoms. We report a group of 10 patients with severe Parkinson's disease. All patients suffered motor fluctuations, dyskinesias and episodes of FOG during the on and off state. The patients received a subcutaneous apomorphine bolus, without other dopaminergic medication; an effective dose of apomorphine was considered as one that induced a reduction of at least a 60% in the UPDRS motor scale. The baseline motor UPDRS was 61.3 +/- 4.7, which dropped to 21 +/- 4.3 after the apomorphine injection. The mean dose of apomorphine was 5.5 mg (3-7 mg). The bolus of apomorphine improved the parameters of the gait related to bradykinesia and the tapping tests of the limbs, but the episodes of FOG did not vary significantly between the off and on state. We present a group of 10 patients with freezing of gait episodes that did not improve with treatment and persisted during the on period induced by dopaminergic stimulus with apomorphine.</abstract><cop>Spain</cop><pmid>20388458</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0213-4853
ispartof Neurología (Barcelona, Spain), 2010-01, Vol.25 (1), p.27-31
issn 0213-4853
language spa
recordid cdi_proquest_miscellaneous_756294944
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Aged
Antiparkinson Agents - therapeutic use
Apomorphine - therapeutic use
Dopamine - therapeutic use
Dopamine Agents - therapeutic use
Dyskinesias - drug therapy
Dyskinesias - etiology
Dyskinesias - physiopathology
Gait
Humans
Middle Aged
Parkinson Disease - complications
Parkinson Disease - drug therapy
Parkinson Disease - physiopathology
Treatment Outcome
title Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Freezing%20of%20gait%20unresponsive%20to%20dopaminergic%20stimulation%20in%20patients%20with%20severe%20Parkinsonism&rft.jtitle=Neurolog%C3%ADa%20(Barcelona,%20Spain)&rft.au=Vaamonde%20Gamo,%20J&rft.date=2010-01&rft.volume=25&rft.issue=1&rft.spage=27&rft.epage=31&rft.pages=27-31&rft.issn=0213-4853&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E756294944%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=756294944&rft_id=info:pmid/20388458&rfr_iscdi=true